By enhancing insulin secretion and reducing sugar release from the liver, both medications help improve overall blood sugar control
When it comes to weight loss, there are no quick fixes, but medications are available to assist you
GLP-1 (Glucagon-Like Peptide-1) and its analogs are structurally complex peptides that require precise analytical characterization of GLP-1 peptide drugs
This product is an unapproved research compound for in-vitro laboratory use only
Gallbladder issues: According to clinical trials, about 2 to 3 percent of people taking either Saxenda or Victoza experienced gallbladder disease, so visit your doctor if you experience symptoms like abdominal pain, jaundice, and fever
The glucagon receptor activation appears to contribute to quicker metabolic response, while the GIP component may help reduce early nausea that can slow initial adaptation to GLP-1 medications